Genetic Immunity is a US clinical-stage biotechnology company focusing on the discovery, development and commercialization of a new class of therapeutic vaccines ("Immune Therapies") for the treatment of chronic viral infections (HIV, HPV), cancer and allergies. Our Immune Therapies are designed to intensify and boost specific immune response to modify or control these presently incurable diseases. We believe our products will allow people to live better, healthier and longer lives.
|Price||1.00 USD||Sale||10,000,000||Payment Mode||ETH|
|Minimum Investment||0.1 ETH||Distribution||50%||Raised||Unknown|
|Soft Cap||N/A||Hard Cap||10 000 000 DER|